NeuroTherapia is presenting results from its Phase 2a clinical trial of NTRX-07 at the Alzheimer's Association International Conference in London. The 28-day study of 48 patients with mild cognitive impairment or Alzheimer's revealed encouraging pharmacodynamic signals, supporting the drug's role in modulating neuroinflammation.
Shanghai-based mobile game publisher Gamehaus Holdings Inc. has received a formal warning from Nasdaq after its Class A ordinary shares traded below the mandatory $1.00 threshold for 30 consecutive business days, triggering a countdown for the company to restore its market standing or face potential delisting.
Scottsdale-based Taylor Morrison secured the 356th spot on TIME’s inaugural America’s Best Companies ranking, positioning itself as the highest-rated homebuilder in the nation. The selection process prioritized a blend of corporate accountability, robust financial performance, and transparency in sustainability reporting.
Logistics group OB Streem, a portfolio company of H.I.G. Capital, has acquired Med Frigo S.A. to bolster its temperature-controlled shipping network. The deal integrates Med Frigo’s specialized cold-chain infrastructure into OB Streem’s existing operations, enhancing its capacity to move fresh aquaculture exports across European markets.
The global market for electric vehicle charging cables is set for rapid expansion, projected to climb from $2.01 billion in 2026 to $5.63 billion by 2033. This growth, representing a compound annual rate of 15.8%, is fueled by the worldwide transition to high-power DC charging and 800V vehicle architectures.
Two distinct construction sites are now active in Pensacola, marking a strategic shift for Innisfree Hotels. The company is balancing a massive expansion of its tourism portfolio on the Gulf Coast with a targeted investment in youth education, aiming to funnel hospitality profits directly into local community infrastructure.
INTCO Medical slashed its carbon emissions per glove to 18.14 grams in 2025, marking an 11.14% drop from the previous year and a 32.5% decrease against its 2022 baseline. This accelerated progress allows the Zibo-based manufacturer to outpace its long-term goal of a 25% reduction by 2030.
With an S+ rating on Yunhe and an 8.1 score on Weibo, Tencent Video’s latest social experiment is dominating Chinese airwaves. By placing 15 celebrities into an unfinished industrial space in Chongqing for 21 days, the show has tapped into a cultural appetite for raw, unscripted human connection in modern urban life.
A sea of 60,000 cosplayers and a thousand anime-themed vehicles transformed Shanghai’s National Exhibition and Convention Center this week, as BilibiliWorld 2026 concluded its three-day run. The event drew 400,000 visitors from over 30 countries, cementing its status as the largest ACGN convention in Asia by footprint and attendance.
A new analysis presented at the Alzheimer's Association International Conference suggests that the experimental drug LM11A-31 may preserve vital communication networks in the brains of patients with mild-to-moderate Alzheimer's disease, offering a potential path to slowing cognitive decline through the stabilization of synaptic resilience.
With national blood reserves falling by a quarter in June, the American Red Cross has officially declared an emergency shortage. The decline, driven by the seasonal loss of school-based blood drives and summer travel, leaves trauma centers and maternity wards scrambling to maintain life-saving operations for critical patients.
Investors who purchased Via Transportation, Inc. securities following the company’s September 2025 initial public offering are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding its financial health and the stability of its expansion efforts in Germany.
Investors who purchased Verra Mobility Corporation stock between February 24 and May 26, 2026, are being urged to join a securities class action lawsuit. The Schall Law Firm alleges the company misled shareholders regarding its growth prospects and the stability of its vital relationship with Avis Budget Group.
Number: Carbon emissions per glove at INTCO Medical dropped to 18.14 grams of CO2 equivalent in 2025, an 11.14% year-over-year decline that puts the manufacturer 32.5% below its 2022 baseline and well ahead of its 2030 reduction targets as the firm pushes toward full carbon neutrality by 2050.
Nanjing-based Leads Biolabs has secured six research slots at the upcoming European Society for Medical Oncology Annual Congress in Madrid, including two high-profile oral presentations. The selection signals growing international interest in the firm's pipeline, particularly its pan-tumor immunotherapy candidate, Opamtistomig, and its GPRC5D-targeting T-cell engager, LBL-034.
Seoul-based Boostimmune has secured a Japanese patent for a novel immuno-oncology technology that prevents the accumulation of myeloid-derived suppressor cells (MDSCs) within tumors. By neutralizing translationally controlled tumor protein (TCTP) released by dying cancer cells, the therapy aims to restore the immune system’s ability to attack malignant growths.
Investors who held GeneDx Holdings Corp. shares between April 16, 2025, and May 4, 2026, are being urged to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centered on claims that the company misled the market regarding its financial health and earnings potential.
After two decades of sourcing stones for luxury brands, gemologist Erica Silverglide is stepping into the spotlight with Ignite. The debut collection from her brand, GemologyGeek, pivots away from mass-market jewelry by focusing on one-of-a-kind pieces that highlight the rare, natural phenomenon of diamond fluorescence.
Investors who purchased Futu Holdings Limited shares between May 24, 2023, and May 27, 2026, face an August 25 deadline to join a class action lawsuit. The litigation alleges the company misled shareholders regarding its regulatory standing and licensing requirements within the Chinese market.
A federal class action lawsuit now targets GRAIL, Inc. following allegations that the biotechnology firm misled shareholders regarding the results of its NHS-Galleri clinical trial. The litigation, filed under the Securities Exchange Act, covers investors who acquired shares between May 13, 2025, and February 19, 2026.
Investors who purchased Hub Group, Inc. shares between April 28, 2023, and May 11, 2026, are being urged to join a securities class action lawsuit. Filed by the DJS Law Group, the complaint alleges the company provided false financial data, including inflated revenue recognition and operating income figures.
Investors who purchased PicS N.V. Class A common stock during the company’s January 2026 initial public offering have until August 4, 2026, to seek appointment as lead plaintiff in a federal class action lawsuit filed against the Brazilian digital bank and its top executives.
Investors who held Peabody Energy stock between October 2024 and May 2026 are facing a potential financial reckoning after a class action lawsuit alleged the company misled the market regarding the production trajectory of its Centurion mine. The legal action centers on claims of material misstatements regarding operational progress.
Investors who purchased Photronics, Inc. shares between December 10, 2025, and May 27, 2026, are being urged to join a class action lawsuit. The DJS Law Group filed the action, alleging that the company misled the market regarding the strength of its high-end product pipeline and business momentum.
Investors who purchased AeroVironment, Inc. stock between June 25, 2025, and March 10, 2026, are being urged to contact DJS Law Group regarding a securities class action. The lawsuit alleges that the company misled shareholders concerning its competitive standing for U.S. Space Force contracts.
Laura Chaubard, the former Director General of École Polytechnique and a General Engineer of Armament, will assume leadership of Sopra Steria’s Defence, Security and Space vertical on September 1, 2026. Her appointment signals a shift toward bolstering European technological sovereignty amid surging regional military spending.
Shareholders of Badger Meter, Inc. have initiated a class action lawsuit alleging the company misled the market regarding its financial health. The complaint claims the firm artificially bolstered its performance by pulling forward customer orders while publicly attributing success to sustainable growth drivers during the period from April 2024 to April 2026.
Investors who purchased ADMA Biologics stock between August 9, 2024, and March 25, 2026, are being urged to join a class action lawsuit. The DJS Law Group is spearheading the litigation, alleging that the company misled the market regarding its financial health and internal sales practices.
Investors who purchased BitGo Holdings stock following the company’s January 22, 2026, initial public offering are now part of a federal securities class action. The lawsuit alleges that BitGo misled the market by inflating its financial outlook while obscuring the impact of declining digital asset prices on its operations.
.jpg)
Investors who purchased Black Rock Coffee Bar shares between September 12, 2025, and May 12, 2026, are being urged to join a class action lawsuit. The litigation targets the company for allegedly issuing misleading statements regarding its store expansion strategy and the impact of new locations on existing performance.
